Literature DB >> 21286474

In vivo Tracking of Transplanted Bone Marrow-Derived Mesenchymal Stem Cells in a Murine Model of Stroke by Bioluminescence Imaging.

Kyung-Sool Jang1, Kwan-Sung Lee, Seung-Ho Yang, Sin-Soo Jeun.   

Abstract

OBJECTIVE: This study was designed to validate the cell trafficking efficiency of the in vivo bioluminescence image (BLI) study in the setting of transplantation of the luciferase expressing bone marrow-derived mesenchymal stem cells (BMSC), which were delivered at each different time after transient middle cerebral artery occlusion (MCAO) in a mouse model.
METHODS: Transplanting donor BMSC were prepared by primary cell culture from transgenic mouse expressing luciferase (LUC). Transient focal infarcts were induced in 4-6-week-old male nude mice. The experiment mice were divided into five groups by the time of MSC transplantation : 1) sham-operation group, 2) 2-h group, 3) 1-day group, 4) 3-day group, and 5) 1- week group. BLI for detection of spatial distribution of transplanted MSC was performed by detecting emitted photons. Migration of the transplanted cells to the infarcted area was confirmed by histological examinations. Differences between groups were evaluated by paired t-test.
RESULTS: A focal spot of bioluminescence was observed at the injection site on the next day after transplantation by signal intensity of bioluminescence. After 4 weeks, the mean signal intensities of 2-h, 1-day, 3-day, and 1-week group were 2.6×10(7) ± 7.4×10(6), 6.1×10(6) ± 1.2×10(6), 1.7×10(6) ± 4.4×10(5), and 8.9×10(6) ± 9.5×10(5), respectively. The 2-h group showed significantly higher signal intensity (p < 0.01). The engrafted BMSC showed around the infarct border zones on immunohistochemical examination. The counts of LUC-positive cells revealed the highest number in the 2-h group, in agreement with the results of BLI experiments (p < 0.01).
CONCLUSION: In this study, the results suggested that the transplanted BMSC migrated to the infarct border zone in BLI study and the higher signal intensity of LUC-positive cells seen in 2 hrs after MSC transplantation in MCAO mouse model. In addition, noninvasive imaging in real time is an ideal method for tracking stem cell transplantation. This method can be widely applied to various research fields of cell transplantation therapy.

Entities:  

Keywords:  Bioluminescence image; Bone marrow-derived mesenchymal stem cells; Stroke

Year:  2010        PMID: 21286474      PMCID: PMC3030077          DOI: 10.3340/jkns.2010.48.5.391

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  30 in total

1.  Using bone marrow stromal cells for treatment of stroke.

Authors:  David A Rempe; Thomas A Kent
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

Review 2.  Mechanisms, challenges and opportunities in stroke.

Authors:  Eng H Lo; Turgay Dalkara; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

3.  Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells.

Authors:  A Mahmood; D Lu; L Wang; Y Li; M Lu; M Chopp
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

4.  Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.

Authors:  J Chen; Y Li; L Wang; Z Zhang; D Lu; M Lu; M Chopp
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

5.  Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

Authors:  Jieli Chen; Yi Li; Mark Katakowski; Xiaoguang Chen; Lei Wang; Dunyue Lu; Mei Lu; Subhash C Gautam; Michael Chopp
Journal:  J Neurosci Res       Date:  2003-09-15       Impact factor: 4.164

6.  Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
Journal:  Brain Res       Date:  2007-09-22       Impact factor: 3.252

7.  Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage.

Authors:  Michel Modo; R Paul Stroemer; Ellen Tang; Sara Patel; Helen Hodges
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

8.  Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.

Authors:  Y Li; J Chen; X G Chen; L Wang; S C Gautam; Y X Xu; M Katakowski; L J Zhang; M Lu; N Janakiraman; M Chopp
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

9.  Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells.

Authors:  Yi Li; Jieli Chen; Chun Ling Zhang; Lei Wang; Dunyue Lu; Mark Katakowski; Qi Gao; Li Hong Shen; Jing Zhang; Mei Lu; Michael Chopp
Journal:  Glia       Date:  2005-02       Impact factor: 7.452

10.  Imaging of stem cell recruitment to ischemic infarcts in a murine model.

Authors:  Dong-Eog Kim; Dawid Schellingerhout; Ken Ishii; Khalid Shah; Ralph Weissleder
Journal:  Stroke       Date:  2004-02-26       Impact factor: 7.914

View more
  13 in total

1.  Tracking fusion of human mesenchymal stem cells after transplantation to the heart.

Authors:  Brian T Freeman; Nicholas A Kouris; Brenda M Ogle
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

2.  Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease.

Authors:  Antonio C Campos de Carvalho; David C Spray; Linda A Jelicks; Herbert B Tanowitz; Vera Maria Peters; Rosalia Mendez-Otero
Journal:  Microbes Infect       Date:  2014-09-16       Impact factor: 2.700

3.  Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.

Authors:  B R Achyut; Adarsh Shankar; A S M Iskander; Roxan Ara; Robert A Knight; Alfonso G Scicli; Ali S Arbab
Journal:  Cancer Biol Ther       Date:  2016-01-21       Impact factor: 4.742

4.  Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go?

Authors:  Linda A Jelicks; Wade Koba; Herbert B Tanowitz; Rosalia Mendez-Otero; Antonio C Campos de Carvalho; David C Spray
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

5.  Regulation of Immunity via Multipotent Mesenchymal Stromal Cells.

Authors:  Y P Rubtsov; Y G Suzdaltseva; K V Goryunov; N I Kalinina; V Y Sysoeva; V A Tkachuk
Journal:  Acta Naturae       Date:  2012-01       Impact factor: 1.845

6.  Granulocyte-macrophage colony-stimulating factor-transfected bone marrow stromal cells for the treatment of ischemic stroke.

Authors:  Xingjian Lin; Yingdong Zhang; Weiguo Liu; Jingde Dong; Jie Lu; Qing Di; Jingping Shi
Journal:  Neural Regen Res       Date:  2012-06-05       Impact factor: 5.135

Review 7.  Magnetic resonance imaging of transplanted stem cell fate in stroke.

Authors:  Hamid Reza Aghayan; Masoud Soleimani; Parisa Goodarzi; Abbas Norouzi-Javidan; Seyed Hasan Emami-Razavi; Bagher Larijani; Babak Arjmand
Journal:  J Res Med Sci       Date:  2014-05       Impact factor: 1.852

8.  Non-invasive in vivo molecular imaging of intra-articularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment.

Authors:  Bou-Yue Peng; Chi-Sheng Chiou; Navneet Kumar Dubey; Sung-Hsun Yu; Yue-Hua Deng; Feng-Chou Tsai; Han-Sun Chiang; Ying-Hua Shieh; Wei-Hong Chen; Win-Ping Deng
Journal:  Oncotarget       Date:  2017-09-27

9.  Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.

Authors:  Jay T Myers; Deborah S Barkauskas; Alex Y Huang
Journal:  Stem Cells Int       Date:  2013-03-27       Impact factor: 5.443

10.  In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging.

Authors:  Juan Cao; Shike Hou; Hui Ding; Ziquan Liu; Meijuan Song; Xiaojing Qin; Xue Wang; Mengyang Yu; Zhiguang Sun; Jinyang Liu; Shuli Sun; Peixin Xiao; Qi Lv; Haojun Fan
Journal:  Stem Cells Int       Date:  2016-08-17       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.